Risk Of Pulmonary Artery Thrombosis In Type 2 DM Patients Hospitalized With Covid-19 | Zendy

Nodirbek Ilkhomjon Ogli Yakubov | Zendy; Dilfuzahon Mamarasulova | Zendy; Nataliya Gamletovna Dadamyants | Zendy; Anvar Arabbayevich Dalimov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk Of Pulmonary Artery Thrombosis In Type 2 DM Patients Hospitalized With Covid-19

Author(s) -

Nodirbek Ilkhomjon Ogli Yakubov,

Dilfuzahon Mamarasulova,

Nataliya Gamletovna Dadamyants,

Anvar Arabbayevich Dalimov

Publication year - 2021

Publication title -

the american journal of medical sciences and pharmaceutical research

Language(s) - English

Resource type - Journals

ISSN - 2689-1026

DOI - 10.37547/tajmspr/volume03issue08-07

Subject(s) - medicine , cardiology , thrombosis , thrombus , type 2 diabetes , proinflammatory cytokine , body mass index , ferritin , venous thrombosis , covid-19 , diabetes mellitus , disease , inflammation , infectious disease (medical specialty) , endocrinology

For the first time on the Fergana Valley model, prognostic markers of the risk of thrombotic complications in COVID-19 patients with type 2 diabetes were studied. It was found that the level of glycemia, the concentration of proinflammatory cytokines IL-6, ferritin and CRP, and the marker of thrombus formation - d dimer, have a prognostic significance, with the maximum prognostic significance of the concentration of CRP. The prognostic significance of ultrasound in the aspect of thrombosis of the branches of the PA in patients with COVID-19 against the background of type 2 diabetes was established. Predictor markers are mean PA pressure, LV myocardial mass index, signs of increased intraventricular pressure in the RV, and evidence of peripheral venous thrombosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research